These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 21482963)
21. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Antzelevitch C; Belardinelli L; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Thomas G Circulation; 2004 Aug; 110(8):904-10. PubMed ID: 15302796 [TBL] [Abstract][Full Text] [Related]
25. Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes. Guo D; Liu Q; Liu T; Elliott G; Gingras M; Kowey PR; Yan GX J Cardiovasc Pharmacol; 2011 Jan; 57(1):79-85. PubMed ID: 20980921 [TBL] [Abstract][Full Text] [Related]
26. Ranolazine for congenital and acquired late INa-linked arrhythmias: in silico pharmacological screening. Moreno JD; Yang PC; Bankston JR; Grandi E; Bers DM; Kass RS; Clancy CE Circ Res; 2013 Sep; 113(7):e50-e61. PubMed ID: 23897695 [TBL] [Abstract][Full Text] [Related]
27. Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2. Parikh A; Mantravadi R; Kozhevnikov D; Roche MA; Ye Y; Owen LJ; Puglisi JL; Abramson JJ; Salama G Heart Rhythm; 2012 Jun; 9(6):953-60. PubMed ID: 22245792 [TBL] [Abstract][Full Text] [Related]
28. Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain. Hoyer K; Song Y; Wang D; Phan D; Balschi J; Ingwall JS; Belardinelli L; Shryock JC J Pharmacol Exp Ther; 2011 May; 337(2):513-23. PubMed ID: 21325441 [TBL] [Abstract][Full Text] [Related]
29. Ranolazine attenuates the enhanced reverse Na⁺-Ca²⁺ exchange current via inhibiting hypoxia-increased late sodium current in ventricular myocytes. Wang XJ; Wang LL; Fu C; Zhang PH; Wu Y; Ma JH J Pharmacol Sci; 2014; 124(3):365-73. PubMed ID: 24572816 [TBL] [Abstract][Full Text] [Related]
30. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation. Eckardt L; Breithardt G; Haverkamp W J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098 [TBL] [Abstract][Full Text] [Related]
31. Oscillations of cardiac wave length and proarrhythmia. Hondeghem LM; Dumotier B; Traebert M Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):367-76. PubMed ID: 20803191 [TBL] [Abstract][Full Text] [Related]
32. An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts. Wu L; Shryock JC; Song Y; Belardinelli L J Pharmacol Exp Ther; 2006 Feb; 316(2):718-26. PubMed ID: 16234410 [TBL] [Abstract][Full Text] [Related]
33. Tolterodine reduces veratridine-augmented late I Wang C; Wang LL; Zhang C; Cao ZZ; Luo AT; Zhang PH; Fan XR; Ma JH Acta Pharmacol Sin; 2016 Nov; 37(11):1432-1441. PubMed ID: 27569391 [TBL] [Abstract][Full Text] [Related]
34. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents. Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351 [TBL] [Abstract][Full Text] [Related]
35. Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation. Thomsen MB; Oros A; Schoenmakers M; van Opstal JM; Maas JN; Beekman JD; Vos MA Cardiovasc Res; 2007 Feb; 73(3):521-30. PubMed ID: 17196569 [TBL] [Abstract][Full Text] [Related]
36. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits. Wang WQ; Robertson C; Dhalla AK; Belardinelli L J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148 [TBL] [Abstract][Full Text] [Related]
37. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. Song Y; Shryock JC; Wagner S; Maier LS; Belardinelli L J Pharmacol Exp Ther; 2006 Jul; 318(1):214-22. PubMed ID: 16565163 [TBL] [Abstract][Full Text] [Related]
38. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017 [TBL] [Abstract][Full Text] [Related]
39. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. Song Y; Shryock JC; Belardinelli L Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2031-9. PubMed ID: 18310511 [TBL] [Abstract][Full Text] [Related]
40. Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts. Chu Y; Yang Q; Ren L; Yu S; Liu Z; Chen Y; Wei X; Huang S; Song L; Zhang P; Ma J; Wu L J Cardiovasc Pharmacol; 2020 Oct; 76(4):437-444. PubMed ID: 32675747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]